5-Amino-1MQ: Patient Information & Safety Notes
Other names: 5-amino-1-methylquinolinium, 5a1mq
5-Amino-1MQ is a laboratory research compound that inhibits nicotinamide N-methyltransferase (NNMT). Preclinical studies have examined NNMT-related metabolic pathways, but there is no established human clinical evidence and it is not approved by the FDA.
In plain language
What 5-Amino-1-Methylquinolinium is used for
- Studied in laboratory and animal models of NNMT-related metabolic pathways
Taking this medicine
How it is administered
- Oral capsule
Read before you decide
Risks and precautions
Risks and warnings
- Insomnia if taken late in the day (reported anecdotally)
- Human safety profile not established
Who should not take it
- Pregnancy or breastfeeding
- History of myocardial infarction or atrial fibrillation (cardiovascular precaution)
Common questions
Patient questions
Is 5-Amino-1MQ approved or safe?
No. 5-Amino-1MQ is a research compound with no FDA approval and no established human clinical evidence of safety or effectiveness. Individuals interested in weight management should discuss FDA-approved options with a licensed provider.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.